Navigation Links
Symposium focuses on curable cancer that affects young men
Date:5/14/2008

The latest information on the biology and treatment of testicular cancer, the most common cancer among young men, will be presented at the Symposium on Testicular Cancer organized by the European Society for Medical Oncology (ESMO), to be held on 15-16 May in Munich, Germany.

"Testicular cancer is the most common tumor in men between the ages of eighteen and thirty-five and has seen the strongest increase in incidence among all cancer types over the last 20 years," said the Symposium's Scientific Chair Prof. Hans-Joachim Schmoll, Director of the Department of Internal Medicine for oncology and hematology at the Martin Luther University Halle and former president of the German association for medical oncology (AIO).

Currently, testicular cancer affects one in every 100 men per year in Europe. The causes of the dramatic rise in incidence remain unclear.

The cure rate for testicular cancer has increased dramatically in recent years, thanks to improvements in chemotherapy. As a result, the treatment strategies in virtually all stages of the disease have changed, away from aggressive surgical or radiation treatment to surveillance without treatment or minimal treatment for most patients in early stages and only limited chemotherapy in advanced stages.

"All these changes in treatment approach mean patients need highly informed and experienced doctors, both to give them the best advice on selecting optimal treatment and then to implement with expertise the adopted course," Prof. Schmoll continued.

The ESMO Symposium on Testicular Cancer will present cutting-edge information on the molecular background of testicular cancer. Sessions will focus on explaining the sensitivity of this tumor to chemotherapy, on prognostic factors and on practical decision-making options for individual patients. In particular, treatment options will be discussed against the background of the European Consensus Guidelines.

After the public meeting, the Symposium Faculty will convene for the ESMO International Consensus meeting on Testicular Tumors, to both elaborate several important topics in the field and to update the ESMO Clinical Recommendations (CR) on Testicular seminoma.

Highlights of the meeting include sessions on the biology of germ cell tumors, with presentations by J. Wolter Oosterhuis from the Netherlands and Ewa Rajpert-De Meyts from Denmark. Darren Feldman from the US will also present brand new data on why germ cell tumors are so platinum sensitive and some resistant.


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
0041-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. 2nd ESMO symposium on soft tissue carcinomas and GIST
2. Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium
3. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
4. Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies
5. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
6. ATS Medical Announces First Frontiers in Cryoablation Symposium
7. Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award
8. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
9. 5W Public Relations Presents the 2008 Body Beautiful Media Symposium Benefiting The Skin Cancer Foundation
10. Symposium to explore role nanoparticles may play in disease
11. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Abilene, Texas (PRWEB) , ... February 24, 2017 , ... ... article that focuses on Bible Prophecy concerning this present generation. Yisrayl makes an ... of this current generation. He explains that the Bible details the current times ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... qualifying into the Senior International Elite division on February 12th. Ms. Esparza ... divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida is ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Club in Miami Beach to host its Swirl: Miami Wine Tasting Event on ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... PHILADELPHIA (PRWEB) , ... February 23, 2017 , ... ... risk and uncertainty in clinical trials, today announced that Premier Research, a leading ... management solution. , Clinical trials are becoming increasingly complex, due in part to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... and Markets has announced the addition of the "Dry eye Drugs ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... following questions: What are the key drugs ... in the Global Dry eye market? What are the ...
(Date:2/24/2017)... 2017 The U.S. Food and Drug ... Kit, performed on the Pheno System. This is ... bloodstream infections and provide information about which antibiotics ... sensitivity). The test also reduces the amount of ... which can guide antibiotic treatment recommendations more quickly. ...
(Date:2/24/2017)... -- This report analyzes the worldwide markets for Chiral Technology ... Products: Intermediates, Analytical, and Others. The End Use markets ... The report provides separate comprehensive analytics for the US, ... , and Rest of World. Annual estimates and forecasts ... a six-year historic analysis is provided for these markets. ...
Breaking Medicine Technology: